The emerge of a pandemic Current understanding of COVID-19 How to detect SARS-CoV-2 infection Management of COVID-19 Long COVID Vaccination—once and for all?

The discovery that D-dimer may be elevated in COVID-19 was first reported by physicians in Wuhan, China where the epidemic started.

Evidence of a potential role for D-dimer and Procalcitonin testing used to assess comorbidities of patients hospitalized with COVID-19

The diagnosis of pulmonary embolism is challenging due to the non-specificity of signs and symptoms and the very busy Emergency Departments to which the overall majority of patients with suspected PE present. While several well-validated diagnostic algorithms exist and are readily available, it is known that in many...

This article discusses the use of a D-dimer assay in excluding venous thromboembolism (VTE) in outpatients. Together with a low pretest probability of VTE, a negative D-dimer test can rule out VTE in 30-50 % of suspected patient cases. The article highlights the importance of using a D-dimer assay with particular...

Dyspnea (alternative names: breathlessness and shortness of breath) is a common reason for individuals to seek medical help either in primary care or the hospital emergency room. The possible causes are legion, so that assessment of the patient complaining of breathlessness is a common and often difficult diagnostic...

When a new D-dimer method is evaluated, it’s typically compared to an established D-dimer method using both an analytical and a clinical comparison. Analytical comparisons should be discouraged, as they do not give any useful information about the potential clinical usability of the assay. D-dimer assay comparisons...

The D-dimer blood test is a clinical laboratory test that is also increasingly available at the point of care, most often the hospital emergency room. Over the past decade or so the test has become established for emergency room assessment of patients suspected of suffering deep vein thrombosis or pulmonary embolism,...

Clinical sensitivity, clinical specificity and predictive values are frequently used as performance measure for a biochemistry assay. When D-dimer assay performance is presented, emphasis is often on the negative predictive value (NPV). However, predictive values are greatly influenced by the prevalence of the...

This article first appeared in Pathology in Practice (Hobba H, Silver L. Evolution of POC testing. Pathology in Practice 2013; 14 [2]: 63) and is reproduced here by kind permission (www.pathologyinpractice.com). © 2013 kdm communications limited Point-of-care (POC) testing has allowed the pathology department in...